Medication Safety

Tenecteplase is here: Navigating the shift of a stroke thrombolytic in the United States prior to FDA approval: a mini-review on rationale, barriers and pathways

Authors: Julian M. Burwell, Jason R. Howay, Lisa Wasko, Samantha Doucoure, Jamie L. Kerestes, Clemens M. Schirmer, David Ermak, Anthony Noto, Philipp Hendrix Until March 2025, alteplase (TPA) was the sole thrombolytic agent approved by the U.S. Food and Drug Administration (FDA) for the treatment of acute ischemic stroke
Enterprise Pharmacy

Restoring cleanroom integrity: HVAC renovations at 2 primary compounding locations

Author: Adam Castro In 2024, Geisinger completed critical heating, ventilation and air conditioning (HVAC) renovations at 2 of its primary sterile compounding locations — Geisinger Wyoming Valley (GWV) operating rooms and Geisinger Medical Center (GMC) Hematology/Oncology Biologics Pharmacy suite. These upgrades addressed longstanding environmental control challenges that directly impacted sterile
Enterprise Pharmacy

Medication reconciliation transformation: Enhancing safety across the care continuum

Author: Brian Simpkins Geisinger has launched a multi-phase initiative to improve medication reconciliation processes across the system, with a focus on strengthening patient safety and care continuity from admission through discharge. The effort addresses longstanding challenges related to medication accuracy, workflow consistency and system integration. The initial phase targets
Enterprise Pharmacy